SAN DIEGO --(BUSINESS WIRE)--Oct. 17, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, plans to release its third quarter 2018 results after the financial markets close

SAN DIEGO --(BUSINESS WIRE)--Oct. 12, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has received a Heath Canada Medical Device License

Continued Domestic Demand and International Launch of the t:slim X2 Insulin Pump Drive Growth SAN DIEGO --(BUSINESS WIRE)--Sep. 25, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring

SAN DIEGO --(BUSINESS WIRE)--Sep. 12, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced it will host an Institutional Investor and Analyst Day from 8:30am

SAN DIEGO --(BUSINESS WIRE)--Aug. 29, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that Kim Blickenstaff , president and CEO, will present a company

SAN DIEGO --(BUSINESS WIRE)--Aug. 17, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2™ Insulin Pump with Basal-IQ™

SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has fully repaid its term loan made by Capital

Study Demonstrates Significant Reduction in Hypoglycemia without Rebound Hyperglycemia SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM)

SAN DIEGO --(BUSINESS WIRE)--Aug. 7, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), (“Tandem”) a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the closing of its previously announced underwritten public offering

SAN DIEGO --(BUSINESS WIRE)--Aug. 3, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem”), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of 3,508,770 shares of

SAN DIEGO --(BUSINESS WIRE)--Aug. 2, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem”), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has commenced a proposed underwritten public offering of its

SAN DIEGO --(BUSINESS WIRE)--Jul. 30, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pump available in the United States , today reported its financial results for the quarter ended June 30, 2018 .

SAN DIEGO --(BUSINESS WIRE)--Jul. 16, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its second quarter 2018 results after the financial markets close on Monday,

New Predictive Low Glucose Suspend Feature to Launch with Dexcom G6 CGM System Integration SAN DIEGO --(BUSINESS WIRE)--Jun. 21, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today

SAN DIEGO --(BUSINESS WIRE)--May 9, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the

SAN DIEGO --(BUSINESS WIRE)--May 1, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the

SAN DIEGO --(BUSINESS WIRE)--Apr. 30, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced receipt of CE mark approval for the t:slim X2™ Insulin Pump with Dexcom G5® Mobile continuous glucose monitoring

SAN DIEGO --(BUSINESS WIRE)--Apr. 26, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended March 31, 2018 .

SAN DIEGO --(BUSINESS WIRE)--Apr. 23, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has entered into distribution agreements with Australasian Medical &

SAN DIEGO --(BUSINESS WIRE)--Apr. 18, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its first quarter 2018 results after the financial markets close on Thursday,